Analysts have clear opinions on HOLX.

There are 11 analysts on the Wall offering 12 month price targets for Hologic in the last 3 months. The average price target is $53.72 with a high forecast of $62.00 and a low forecast of $50.00. The average price target represents a -1.10% decrease from the last price of $54.32.
Hologic, Inc. (HOLX) is followed by 11 analysts on the street.

Michael Matson from Needham rates it a Buy with a target of $62.00.

Similarly, 7 days ago Jack Meehan of Barclays Reiterated a Hold with a target of $51.00.

The consensus on the street is Hold.

What does Hologic, Inc.(HOLX) do ?
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.

Hologic, Inc. (HOLX) Insider Trades

Multiple company employees have indulged in significant insider trading. Hologic, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):

GC, Griffin John M. : S – Sale+OE(-$1,037,334) of HOLX in the trading session of 2020-01-13.

CFO Oberton Karleen Marie : S – Sale+OE(-$845,687) of HOLX in the trading session of 2020-01-02.

Principal Accounting Officer Cohn Benjamin Jordan : S – Sale+OE(-$228,225) of Hologic, Inc. in the trading session of 2019-12-04.

Looking for stocks just like HOLX?

Based on Wall Street analyst research, several stocks are similar to HOLX
They are:
– GE [Info can be found here: ]
– RHHBY [Info can be found here: ]
– CUTR [Info can be found here: ]